By EMS1 Staff EMS1.com was founded on July 1, 2007. Since then, we've grown by leaps and bounds. In honor of our 10 year anniversary, here's a snapshot of the top 10 stats from the past decade. Thank you for the opportunity to serve as an essential resource for many in EMS. This image, with attribution to EMS1.com, can be shared and reprinted without alteration. For any other uses contact the ...
from EMS via xlomafota13 on Inoreader http://ift.tt/2uIwS7u
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Abstract Ravulizumab (ravulizumab-cwvz; ULTOMIRIS™), a humanized monoclonal antibody, is a complement C5 inhibitor developed by Alexion Ph...
-
http://bit.ly/2TO0eLw
-
Abstract Objective Long-acting synthetic somatostatin analogues (SSA) are an essential part of the treatment of neuroendocrine neoplasms...
-
Training in teamwork behaviour improves technical resuscitation performance. However, its effect on patient outcome is less clear, partly be...
-
Abstract Chronic low-grade inflammation is now widely accepted as one of the most important contributors to metabolic disorders. Glycoprot...
-
Medicine by Alexandros G. Sfakianakis BioMed Research International BioMed Research InternationalTanshinone IIA Alleviates CCL2-Induced Le...
-
Abstract Chronic venous disease (CVD) is both prevalent and unavoidable in many people as a result of persistent or unalterable risk facto...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου